Do investors have a safe investment in Quantum-Si incorporated (NASDAQ:QSI)?

The price of Quantum-Si incorporated (NASDAQ:QSI) shares last traded on Wall Street rose 8.86% to $2.58.

Based on available information, 1 analysts follow Quantum-Si incorporated (NASDAQ:QSI). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $4.00 and a low of $4.00, we find $4.00. Given the previous closing price of $2.37, this indicates a potential upside of 68.78 percent. QSI stock price is now 57.62% away from the 50-day moving average and 25.12% away from the 200-day moving average. The market capitalization of the company currently stands at $350.75M.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

Among analysts, 0 rate the stock a hold while 1 rate it a buy. Brokers who have rated the stock have averaged $4.00 as their price target over the next twelve months.

With the price target of $13, Canaccord Genuity recently initiated with Buy rating for Quantum-Si incorporated (NASDAQ: QSI).

In other news, LaPointe Christian, General Counsel & Corp. Secr. bought 20,000 shares of the company’s stock on Mar 15. The stock was bought for $35,400 at an average price of $1.77. Upon completion of the transaction, the General Counsel & Corp. Secr. now directly owns 247,693 shares in the company, valued at $0.64 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 15, Director RAKIN KEVIN sold 89,000 shares of the business’s stock. A total of $191,234 was realized by selling the stock at an average price of $2.15. This leaves the insider owning 1,801,000 shares of the company worth $4.65 million. Insiders disposed of 690,000 shares of company stock worth roughly $1.78 million over the past 1 year. A total of 0.20% of the company’s stock is owned by insiders.

There have been several recent changes in the stakes of large investors in QSI stock. A new stake in Quantum-Si incorporated shares was purchased by BRIDGEWAY CAPITAL MANAGEMENT, LLC during the first quarter worth $791,000. JANE STREET GROUP, LLC invested $338,000 in shares of QSI during the first quarter. In the first quarter, POINT72 ASSET MANAGEMENT, L.P. acquired a new stake in Quantum-Si incorporated valued at approximately $79,000. CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. acquired a new stake in QSI for approximately $62,000. Y-INTERCEPT (HONG KONG) LTD purchased a new stake in QSI valued at around $53,000 in the second quarter. In total, there are 141 active investors with 40.00% ownership of the company’s stock.

A candlestick chart of Quantum-Si incorporated (NASDAQ: QSI) showed a price of $2.4300 on Thursday morning. During the past 12 months, Quantum-Si incorporated has had a low of $1.36 and a high of $4.43. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 32.70, and a quick ratio of 32.50. The fifty day moving average price for QSI is $1.6592 and a two-hundred day moving average price translates $2.0616 for the stock.

The latest earnings results from Quantum-Si incorporated (NASDAQ: QSI) was released for Mar, 2023. According to the Biotechnology Company, earnings per share came in at -$0.17, beating analysts’ expectations of -$0.19 by 0.02. This compares to -$0.25 EPS in the same period last year. For the current quarter, analysts expect QSI to generate $400k in revenue.

Quantum-Si incorporated(QSI) Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of protein detection platform to enable Next Generation Protein Sequencing (NGPS). The company’s platform is comprised of the Carbon automated sample preparation instrument; the Platinum single-molecule detection and NGPS instrument with Time-Domain Sequencing chip; the Quantum-Si Cloud data analysis software; and reagent kits for use with its instruments. The company was founded in 2013 is based in Guilford, Connecticut.

Related Posts